Guarino Stephanie Howe, Bakare Olusegun, Jenkins Carolyn M, Williams Kimberly D, Subedi Keshab, Wright Charmaine S, Pachter Lee M, Lanzkron Sophie
Center for Special Health Care Needs, ChristianaCare, Wilmington, DE, USA.
Department of Pediatrics, Nemours Children's Health, Wilmington, DE, USA.
J Pain Res. 2024 Nov 6;17:3601-3618. doi: 10.2147/JPR.S469999. eCollection 2024.
This study sought to adapt a chronic pain group curriculum for adults with sickle cell disease (SCD). Given the association of experiences of racism and discrimination with health outcomes, this study also explored how such experiences for patients with SCD impact their interactions with clinicians and health-care systems.
This mixed methods study recruited patients (aged ≥18 years) in a sickle cell treatment program; all self-identified as Black or African American. Key informant interviews evaluated a chronic pain program curriculum and rated the curriculum sessions' importance for SCD pain management. A survey containing six validated instruments then measured experiences of pain and discrimination, level of emotional expressivity, and trust in physicians and health insurers.
Of the 19 adult patients approached, 12 (63%) completed the interview and survey. Interview data analysis resulted in five themes comprising pain, treatment, mental/emotional, health-care clinicians, and differences in SCD versus other chronic conditions. Each curriculum session was rated as "very important" or "important" by participants. Most described at least one experience of racism or discrimination in the medical setting and identified clinicians' lack of knowledge as a barrier to appropriate SCD care. Participants identified the importance of non-pharmacological treatments for SCD pain and appropriately managing pain caused by comorbid chronic conditions. Conversely, survey responses reported moderate levels of pain, infrequent discriminatory experiences in the medical setting, and moderate trust in medical professionals, whereas most reported experiences of discrimination in general settings. Many participants reported they either accepted it or did nothing in response to discriminatory experiences.
Study findings emphasize the need to address experiences of racism and stigma in addition to experiences of emotional and physical pain among patients with SCD in the context of pain management. Findings from this study will inform the development of a SCD pain group curriculum for adult patients.
本研究旨在改编一套针对镰状细胞病(SCD)成人患者的慢性疼痛群体课程。鉴于种族主义和歧视经历与健康结果之间的关联,本研究还探讨了SCD患者的此类经历如何影响他们与临床医生及医疗保健系统的互动。
这项混合方法研究招募了镰状细胞治疗项目中的患者(年龄≥18岁);所有患者均自我认定为黑人或非裔美国人。关键 informant 访谈评估了一个慢性疼痛项目课程,并对课程环节对SCD疼痛管理的重要性进行了评分。随后,一项包含六种经过验证的工具的调查测量了疼痛和歧视经历、情绪表达水平以及对医生和健康保险公司的信任度。
在19名成年患者中,12名(63%)完成了访谈和调查。访谈数据分析得出了五个主题,包括疼痛、治疗、心理/情绪、医疗保健临床医生以及SCD与其他慢性疾病的差异。参与者将每个课程环节评为“非常重要”或“重要”。大多数人描述了在医疗环境中至少一次种族主义或歧视经历,并指出临床医生缺乏知识是获得适当SCD治疗护理的障碍。参与者确定了非药物治疗对SCD疼痛的重要性以及适当管理由合并慢性疾病引起的疼痛。相反,调查回复显示疼痛程度中等、在医疗环境中歧视经历较少、对医疗专业人员信任度中等,而大多数人报告在一般环境中有歧视经历。许多参与者报告说,他们要么接受歧视经历,要么对此无所作为。
研究结果强调,在SCD患者疼痛管理的背景下,除了应对他们的情感和身体疼痛经历外,还需要解决种族主义和耻辱经历。本研究结果将为为成年患者开发SCD疼痛群体课程提供参考。